Psykey, Inc. (CEOS)

Market Cap	939.24K -91.5%
Revenue (ttm)	n/a
Net Income	-5.01M
EPS	-0.41
Shares Out	313.08M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,000
Average Volume	160,128
Open	0.0030
Previous Close	0.0030
Day's Range	0.0030 - 0.0030
52-Week Range	0.0006 - 0.0165
Beta	0.63
RSI	53.40
Earnings Date	n/a

About Psykey

Psykey, Inc. engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market. Its retail products include functional mushroom coffees and teas, oral supplements, and single serve drink mixes. The company was formerly known as CeCors, Inc. and changed its name to Psykey...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2002
• Employees: 6
• Stock Exchange: OTCMKTS
• Ticker Symbol: CEOS